Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00590941 Information provided by Washington University School of Medicine

First Received: December 28, 2007 Last Updated: October 27, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma
Diffuse Large Cell

Additional conditions recognized in this trial

Lymphoma, Large B-Cell, Diffuse

More general conditions related to this trial

Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Interventions listed in this trial

Blood draw
Rituximab
Cyclophosphamide
Doxorubicin
Vincristine
Prednisone

Sponsors listed in this trial

Washington University School of Medicine
BJC Foundation

Back to top of Main Content